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INTRODUCTION 
Spontaneous Bacterial Peritonitis is an infectious process that usually occurs in 
the cirrhotic patients with ascites, in which a contiguous local source of infection is 
absent.  The diagnosis of Spontaneous Bacterial Peritonitis is made, when there is a 
positive ascitic fluid culture (always monomicrobial) and there is an elevated ascitic 
fluid absolute neutrophil count (at least 250 cells / mm3 or above).  
 Spontaneous Bacterial Peritonitis is a common complication occurring in 
cirrhotic patients, mostly fatal in nature, if left untreated. The mortality ranges from 
48% to 57%1.2. Spontaneous Bacterial Peritonitis is defined as an infection of the 
ascitic fluid in the absence of any intra-abdominal surgically treatable source of 
infection. The prevalence varies from 8% to 27% 3, 4.   
The higher awareness of this entity over the past two decades has decreased the 
threshold for performing diagnostic procedures and has resulted in the large increase 
in the number of patients so diagnosed. 
Though a large amount of information on Spontaneous Bacterial Peritonitis is 
available today, the condition is however under diagnosed because of the following 
facts,  
(i) The protein concentration of ascitic fluid does not increase during Spontaneous 
Bacterial Peritonitis in contrast to other infected body fluid5. 
   
  
(ii)  35% to 58% of patients with Spontaneous Bacterial Peritonitis are culture 
negative by conventional methods.6, 7  
Recurrence of Spontaneous Bacterial Peritonitis occurs in 70% within one year 
after recovery from the first episode.2            
   
 
 
 
 
 
 
 
 
 
 
 
  
 
AIM OF THE STUDY 
1. To study the prevalence of Spontaneous Bacterial Peritonitis in cirrhotic 
patients with ascites. 
2. To study the presenting features of Spontaneous Bacterial Peritonitis. 
3. To study the correlation of severity of liver disease with Spontaneous Bacterial 
Peritonitis. 
4. To study the correlation of ascitic fluid chemistry and cytology with 
Spontaneous Bacterial Peritonitis. 
5. To compare the culture of ascitic fluid using blood culture bottles with that of 
conventional method of culture. 
6. To study the microbiological profile of Spontaneous Bacterial Peritonitis. 
  
 
 
 
 
 
  
REVIEW OF LITERATURE 
Though described first in 1893 by French physicians CHARRIN and 
VEILLON, wide spread recognition came about only in mid 1960’s and 1970’s. 
Numerous retrospective 2,3,8,9 and two prospective studies1 have confirmed the 
importance and prevalence of the Spontaneous Bacterial Peritonitis in cirrhotic 
patients with ascites. 
In the seven papers, which have reported more than 20 cases each of 
Spontaneous Bacterial Peritonitis2, 3, 8, 9 66% of 246 patients were reported to be 
alcoholics and of 177 patients who had histologic evaluation, 68% had alcoholic 
cirrhosis.  However, cirrhosis is not the only condition, which predisposes to 
Spontaneous Bacterial Peritonitis.  This condition was the most common cause of 
death in a childhood series of nephrotic syndrome reported in 1950.  There are also 
case reports of Spontaneous Bacterial Peritonitis in patients with severe viral hepatitis, 
CCF and malignancy related ascites. 
Ascitic fluid infections can be spontaneous or secondary to an intra-abdominal, 
surgically treatable source of infection.  More than 90% of ascitic fluid infections are 
spontaneous.  
 According to the characteristics of ascitic fluid culture and neutrophil count, 
three other variants of ascitic fluid infection have been described in cirrhotic patients 
during the last decade.   
  
(i) Culture negative neutrocytic bacterascites (culture negative 
neutrocytic ascites).   
(ii) Mono-microbial non-neutrocytic bacterascites.   
(iii) Poly-microbial bacterascites. 
VARIANTS OF ASCITIC FLUID INFECTIONS ACCORDING TO ASCITIC 
FLUID CHARACTERISTICS 
Sl.No VARIANTS OF A.F.I A.F.CULTURE 
A.F. PMN 
count/mm3 
1 Spontaneous Bacterial Peritonitis + ≥ 250 
2 Culture negative neutrocytic ascites _ ≥ 250 
3 Mono-microbial non-neutrocytic ascites. + < 250 
4 Secondary bacterial peritonitis + (Single/ multiple org.) ≥ 250 
5 Poly-microbial bacterascites. + (Multiple org.) < 250 
 
Culture negative neutrocytic ascites is defined as ascitic fluid infection in 
which the neutrophil count is 250 or more with no growth of ascitic fluid culture in the 
absence of prior antibiotic therapy and in the absence of another explanation for an 
elevated neutrophil count, such as peritoneal carcinomatosis, tuberculosis or 
pancreatitis6.   34% of culture negative neutrocytic ascites converted to a culture 
positive infection before antibiotic therapy was started, where as 66% of patients 
remained culture negative, usually with a spontaneously declining neutrophil count.  
  
These data suggest that some episodes of culture negative neutrocytic ascites can 
resolve spontaneously.  Therefore, culture negative neutrocytic ascites must be 
considered as a true infection of ascitic fluid and it must be treated with appropriate 
antibiotics. 
Mono-microbial non-neutrocytic ascites is defined as an ascitic fluid infection 
in which neutrophil count is less than 250 cells/mm3 with a positive ascitic fluid 
culture for a single organism.10   It was observed that Mono-microbial non-neutrocytic 
ascites episodes resolved spontaneously in 62% to 86% of patients. 10, 11 All patients 
who progressed to spontaneous bacterial peritonitis had symptoms of bacterial 
infection at the time of first paracentesis.  Therefore, only symptomatic patients with 
Mono-microbial non-neutrocytic ascites appear to require treatment with antibiotics.  
Whereas asymptomatic patients should be treated or reevaluated with a second tap 
before antibiotic treatment is started.  Patients with bacterascites have less severe liver 
disease than patients with spontaneous bacterial peritonitis. 10, 11, 12  
In summary, spontaneous ascitic fluid infection is a very dynamic process.  
Bacteria can resolve spontaneously or progress to spontaneous bacterial peritonitis.  
Although occasionally spontaneous bacterial peritonitis can spontaneously evolve to 
sterile fluid with a declining neutrophil count, this effect is unusual and it cannot be 
relied on or predicted.  An elevated ascitic fluid neutrophil count probably provides 
evidence that peritoneal macrophages have failed to contain bacterial colonization and 
that neutrophils have to be called in as the second line of defence.13   Without 
antibiotic treatment, neutrophils usually fail with resulting uncontrolled infection and 
  
death of the host.  An ascitic fluid neutrophil count of 250 or more should be 
presumed to be caused by bacterial infection and it should be treated empirically with 
antibiotics. 
 Secondary bacterial peritonitis can also develop in the cirrhotic patients.  
Differentiation of spontaneous bacterial peritonitis from secondary bacterial peritonitis 
is very important, because SBP is always treated medically and secondary bacterial 
peritonitis is treated surgically.  Secondary bacterial peritonitis is usually suspected 
when neutrocytic ascitic fluid demonstrates two or three of three of the following 
criteria.14  Total protein level greater than 1 gm/dl, Glucose level less than 50mg/dl, 
and LDH level greater that 225mu/ml.  
 Further more, most ascitic fluid cultures in these patients are poly-microbial, 
whereas in Spontaneous Bacterial Peritonitis they are mono-microbial. 
Poly-microbial bacterascites is another variant of non specific ascitic fluid 
infection.  This is characterized by (i) a neutrophil count of less than 250 cells/mm3 
and multiple organisms on gram stain and culture.  (ii) as a result of needle perforation 
of the gut during attempted paracentesis.  Poly-microbial bacterascites can resolve 
spontaneously without antibiotic treatment, if ascitic fluid protein (and opsonin) 
concentration is adequate. 
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PATHOGENESIS OF SPONTANEOUS BACTERIAL PERITONITIS 
PHYSIOLOGY OF PERITONEUM 
Peritoneum is a complex serous membrane, which lines the abdominal wall and 
is reflected over the viscera within the abdomen.  The parietal and visceral layers are 
developed respectively from the somatopleural and splanchnopleural layers of the 
lateral plate mesoderm.  
The total area of the peritoneal surface in the adults is between 1.5 and 2m2 
approximately equal to the total body surface area.  The blood flow to the peritoneum 
is 50 to 70ml/min.  The normal peritoneum consists of a single layer of flattened 
mesothelial cells.  Micro-villi protrude from the free mesothelial surface which is 
lubricated by a small volume of serous fluid. 
PATHOGENESIS 
Pathogenesis of SBP in patients with cirrhosis is considered to be the main 
consequence of Bacterial Translocation (BT). 
There are some mechanisms that are being proposed to explain BT in cirrhosis, 
(1) The intestinal bacterial overgrowth,  
(2) The structural and functional alterations of the intestinal mucosal 
barrier and  
(3) The deficiencies of the local immune response15, 16. 
  
The intestinal bacterial overgrowth plays a key role in BT in cirrhosis and is the 
result of the delayed intestinal transit existing in these patients.  It seems that the 
sympathoadrenal stimulation, increases NO synthesis and the oxidative stress of the 
mucosa are the main causes for decreased intestinal motility17,18. 
The barrier of the intestinal mucosa includes defence mechanisms of secretory 
or physical type, against the microbial penetration. 
The secretory (first defence) mechanism is realized through the mucus 
secretion, the local immunoglobulins and the bile salts. 
The physical (second defence) mechanism is represented by the intestinal 
epithelium-by its lack of permeability and its antimicrobial peptide active production. 
Among the predisposing factors for SBP, the most important one is the severity 
of liver diseases: about 70% of the patients who develop SBP are in Child C class. 
Besides, a serum bilirubin level > 2.5 mg/dl is an independent predictive factor of 
SBP19. 
20% of the patients have SBP at the time of admission to the hospital and 30-
40% develop bacterial infections, during hospitalization for GI hemorrhage – a 
possible explanation being that the hemorrhagic shock increases BT and intestinal 
permeability.  Also for preventing bacteremia, vascular catheterization has to be 
reduced to the minimum.        
For any infection, there are source of organisms and conditions predisposing to 
the infection.  The presence of ascites alone is not sufficient to result in spontaneous 
  
bacterial peritonitis, since not all forms of ascites are prone for infection.  Cirrhotic 
ascites is similar to most other types of ascites except in its low protein concentration. 
Cirrhosis is also associated with poor clearance of substances from the blood 
including bacteria. 
Spontaneous Bacterial Peritonitis develops in patients with advanced liver 
disease3.  It is a consequence of multiple defects in the immune defence of patients 
with cirrhosis.  Patients with liver disease have deficient serum and ascitic fluid 
complement levels, 20, 21, 22 decreased reticulo-endothelial system phagocytic    
activity, 23, 24 alterations in neutrophil functions 25 and diminished bactericidal and 
opsonic activity of ascitic fluid.26, 27, 28, 29    
  
SOURCE OF BACTERIAL INFECTION AND MODE OF ENTRANCE 
TO THE PERITONEAL CAVITY 
Most cases of spontaneous bacterial peritonitis are not associated with an 
established infection elsewhere in the body and therefore infection in the peritoneal 
fluid must arise from the blood stream or across the intestinal wall.  75% of the 
organisms causing spontaneous bacterial peritonitis are intestinal flora and both 
mechanisms have been implicated.  Evidence favouring a trans-intestinal wall route 
includes the presence of mucosal edema and the demonstration of transfer from lumen 
to the peritoneal cavity of both alive and dead C14 labelled E.coli.  However the 
association of spontaneous bacterial peritonitis with poor clearance of particulate 
matter by reticulo-endothelial cells and with spontaneous bacteremia supports a 
  
bloodborne route, as does infection with organism that does not inhabitat the gut.  
Most non-enteric organisms probably enter the ascitic fluid by one of the two 
following mechanisms,  
(i) Across the sinusoids of liver with subsequent transfer into ascitic 
fluid across the hepatic capsule or  
(ii) Across the capillaries of the intestine with subsequent direct 
anatomic breaks in lymphatics, drawing the infected intestinal fluid. 
The normal intestinal capillary permeability and “Capillarisation of the 
Sinusoids” that occurs with cirrhosis would suggest that the quantity of organisms 
entering either route is small30. 
 
INTRAHEPATIC SHUNTING AND SYSTEMIC CLEARANCE OF 
BACTERIA 
Spontaneous bacteremia is frequent in cirrhosis. The type of organisms in 
Spontaneous bacteremia is primarily enteric and similar to those found in spontaneous 
bacterial peritonitis.  Both syndromes are compatible with the poor first pass removal 
of gut bacteria.  The systemic clearance of substances removed by reticulo-endothelial 
cells and by hepatocytes, decreases in parallel with the severity of chronic liver 
disease and is thought to be due to the hepatic fibrosis producing capillarisation of the 
sinusoids with acinae, septal intrahepatic shunts or both.  Capillarisation of sinusoids 
is the source of deposition of collagen in the space of Disse and sinusoids within the 
  
acinae.  This results in an abnormal distribution of acinar blood flow and the 
separation of hepatocytes from the blood stream.  Septal intra-hepatic shunts are not 
connected with normal acinae since they completely bypass the acinar unit.  
Capillarisation of sinusoids is probably the most frequent causes of intra-hepatic 
shunting in patients with chronic liver disease.  Septal intra-hepatic shunts are 
normally greater than 25 microns in diameter and can be measured by the portal 
injection of microspheres.  Such intra-hepatic shunts increase the exposure of the 
systemic circulation to the gut products.  Since the first pass hepatic clearance is 
decreased and the clearance of these products in the systemic circulation is also 
decreased, intra-hepatic shunting may be a major factor predisposing to spontaneous 
bacterial peritonitis23. 
 
CHARACTERISTICS OF ASCITES PREDISPOSING TO INFECTION 
Spontaneous bacterial peritonitis in cirrhotic patients is rare, in the absence of 
ascites.  Even in the patients in whom clinically detectable ascites appear to follow 
after the evidence of spontaneous bacterial peritonitis has developed, a small amount 
of ascites must have been present prior to the infection.  The rarity of the spontaneous 
bacterial peritonitis in all types of ascites, except secondary to liver disease, may 
highlight the importance of intra-hepatic shunting in predisposing to this syndrome.  
However it may also suggest that Non-cirrhotic ascites is less susceptible to infection.   
The organisms that causes spontaneous bacterial peritonitis are not killed by 
opsonin alone but also require the presence of phagocytic cells31.                      
  
However phagocytic cells, macrophages and PMN are ineffective in phagocytosing 
bacteria in the absence of specific and nonspecific opsonins such as complement, 
fibronectin and immunoglobulins, in patients with cirrhotic ascites compared to 
patients with other forms of ascites. The complement levels in the ascitic fluid are 
directly proportional to the levels of the protein. 
The opsonic activity of the ascitic fluid too correlates closely with the protein 
content9.  Part of the reason for the susceptibility of cirrhotic ascites to spontaneous 
bacterial peritonitis may be the low levels of specific and nonspecific opsonins 
required for the phagocytosis to take place successfully in the fluid.   
Absence of spontaneous bacterial peritonitis in ascites not due to the nephrotic 
syndrome or liver disease may also be related to the higher concentration of protein in 
such fluids and to relative protection that this protein affords against the infection. 
The most common causative organism isolated from the ascitic fluid of these 
patients are Gram negative bacteria especially E.coli and Klebsiella pneumoniae.  
Gram positive cocci are isolated less frequently.  The enteric nature of most organisms 
that cause these infections implicates the gut as their source.  However direct passage 
of bacteria from the intestinal lumen to ascitic fluid has not been documented, unless 
the gut mucosa integrity has been lost32.  
In summary, the pathogenesis of spontaneous bacterial peritonitis is due to the 
combination of prolonged bacteremia due to the intra-hepatic shunting and absence of 
effective bacterial destruction in ascites which has low protein content. 
  
MICROBIOLOGICAL PROFILE OF SBP 
Regarding the etiology, over 60% of the SBP episodes are produced by Gram-
negative enteric bacilli – E.coli and Klebsiella pneumonia being the most frequently 
isolated microorganisms. 33, 34 
It has been ascertained that certain E. coli strains can translocate the intestinal 
mucosa more often – probably because of a higher capacity to adhere to it and because 
of a higher virulence that determines a higher resistance to the defence mechanisms of 
the host. 
In about 25% of the cases, gram-positive cocci are involved: streptococci 
(frequently pneumococcus) and enterococci.35, 36 
Although the bowel flora is predominantly anaerobic, SBP is very seldom 
produced by anaerobic microorganisms, due to their incapacity to translocate the 
intestinal mucosa and due to the high volume of oxygen in the intestinal wall and in 
the tissues that surround it. 
A special situation is represented by the patients that receive antibiotic 
treatment (usually fluoroquinolones) for the inhibition of the gram-negative intestinal 
flora (selective intestinal decontamination), with the purpose of reducing the incidence 
of the SBP episode.  In these patients, an increased frequency of the SBP episodes 
produced by gram-positive bacteria has been ascertained.37   
Streptococci were found more frequently in community-acquired episodes 
(53.8%) than in nosocomial episodes (33.3%).  Gram-negative bacilli were 
  
significantly more frequent in nosocomial episodes than in community-acquired 
episodes.   
MORTALITY / MORBIDITY 
The SBP mortality rate ranges from 40-70% in adults patients with cirrhosis 
and is lower in children with nephrosis. 
• Patients with concurrent renal insufficiency have been shown to be at a 
higher risk of mortality from SBP than those without concurrent renal 
insufficiency. 
• Recent reports show that mortality from SBP may be decreasing among 
all subgroup of patients because of advances in its diagnosis and 
treatment. 
Race:  No race predilection is known. 
Sex:  In patients with ascites, both sexes are affected equally. 
Age:  While the etiology and incidence of hepatic failure differ between children and 
adults, in those individuals with ascites, the incidence of SBP is roughly equal.       
PREDISPOSING FACTORS 
Spontaneous bacterial peritonitis occurs only in the setting of liver disease, for 
all practical purposes.  Specific subsets of patients with cirrhosis and ascites have been 
identified as having an unusually high risk for development of spontaneous bacterial 
peritonitis.   
  
They are  
1. Severity of the liver disease. 
2. Gastro-intestinal Haemorrhage. 
3. Ascitic fluid protein ≤ 1 gm/dl. 
4. UTI 
5. Urinary Bladder Catheters. 
6. Intravascular Catheters. 
7. Previous H/O spontaneous bacterial peritonitis. 
Severity of liver disease is a significant risk factor for spontaneous bacterial 
peritonitis.  95% of patients with spontaneous bacterial peritonitis have an elevated   
Serum Bilirubin and 98% have prolonged prothrombin time. Cirrhotic patients with 
GI Haemorrhage are in fact, at the time of admission, are at risk of developing 
bacterial infections during the initial 3 to 4 days.  Acute haemorrhage depresses the 
reticulo-endothelial functions, alters intestinal permeability and favours bacterial 
translocation, which is higher in the cirrhosis.   
The antimicrobial activity of the ascitic fluid correlates  
(1) Directly with the ascitic fluid protein content and also with the ascitic fluid 
C3 levels and 
  (2) Inversely with risk of spontaneous bacterial peritonitis.  
  
 The total ascitic fluid protein levels less than 1gm/dl is associated with ten fold 
increased risk for development of spontaneous bacterial peritonitis, compared with the 
patients whose ascitic fluid total protein levels are greater than 1gm/dl.  Recurrence is 
also common with lower ascitic fluid protein levels. 
UTI have been reported to be common in patients with cirrhosis.  The 
association between spontaneous bacterial peritonitis and urinary tract infection is 
evident in one of the prospective studies.38  
Invasive procedures other than endoscopy have been incriminated in 
predisposing to bacteremia and spontaneous bacterial peritonitis in cirrhotic patients 
with ascites.  Intravascular and bladder catheters are portals of entry of bacteria into 
these immunocompromised hosts and they should be avoided whenever possible. 
Previous spontaneous bacterial peritonitis episodes may predispose to 
recurrence.  These patients, who are immunodeficient for one spontaneous bacterial 
peritonitis episode, are at a risk for more episodes.  Repeated large volume 
paracentesis have been reported to deplete protein levels and they could predispose to 
spontaneous bacterial peritonitis.  Studies which have compared diuretic therapy to 
paracentesis have shown that, ascitic fluid opsonic activity and C3 levels increased in 
the diuretic group, whereas ascitic fluid opsonic activity remained stable and ascitic 
fluid C3 levels decreased in the single large volume paracentesis plus diuretic group. 
No variations in serum C3 levels were observed.  Diagnostic paracentesis is seldom a 
cause for the development of spontaneous bacterial peritonitis.  Poly-microbial 
  
bacterascites may be possible during paracentesis, where the bowel is entered by the 
paracentesis needle and bowel contents released into the ascitic fluid. 
Bacteremia and spontaneous bacterial peritonitis have been reported after 
endoscopy, particularly after an emergency sclerotherapy.  However, consensus is 
that, development of bacterial infections in bleeding cirrhotic patients treated with 
sclerotherapy may be related more to the GI bleeding than to the endoscopic 
procedure. 
Hepato-cellular carcinoma may suppress the host defenses against bacterial 
infections.  However most patients with tumour have underlying cirrhosis.  Studies 
have shown that the development of spontaneous bacterial peritonitis depends on the 
severity of the underlying liver disease and not due to the presence of the tumour. 39, 40                       
 
 
 
 
 
 
 
 
  
FACTORS NOT PREDISPOSING TO THE DEVELOPMENT OF 
SPONTANEOUS BACTERIAL PERITONITIS 
1. Diagnostic paracentesis 
2. Endoscopy 
3. Sclerotherapy 
4. Banding of the varices 
5. Hepato-cellular carcinoma 
 
DIAGNOSIS 
Clinical signs and symptoms of peritonitis are usually mild in patients with 
spontaneous bacterial peritonitis, compared with patients who have surgical peritonitis 
in the absences of ascites.  The ascitic fluid prevents the development of a surgical 
abdomen.  Fever and abdominal pain are the most common symptoms in spontaneous 
bacterial peritonitis.  A high proportion of patients with spontaneous bacterial 
peritonitis have non-specific symptoms such as hepatic encephalopathy, diarrhoea, 
ileus, hypotension and shock.  More over, spontaneous bacterial peritonitis may 
manifest only as a mild deterioration in mental status or mild azotemia or acidosis.  
10% to 33% of patients with spontaneous bacterial peritonitis may be asymptomatic; 
hence there should be a high index of suspicion to diagnose spontaneous bacterial 
peritonitis. 
  
Ascitic fluid analysis is necessary for the diagnosis of spontaneous bacterial 
peritonitis.  An ascitic fluid PMN count of 250 or more provides presumptive 
evidence of ascitic fluid infection.  Gram stain of ascitic fluid usually demonstrates no 
bacteria in patients with cirrhosis who have spontaneous bacterial peritonitis, because 
concentration is very low (≤ 10 organisms/ml) and about 10,000ml are required before 
bacteria are apparent by this technique.  Gram stain can be very helpful in identifying 
patients with gut perforation, where multiple types of bacteria are seen usually. 
Acute phase reactants are produced during bacterial infections.  The values of 
serum and ascitic fluid acute phase reactants levels in spontaneous bacterial peritonitis 
have been studied.  TNF - α, Interleukin-6, α 1 - antitrypsin and CRP levels are higher 
in infected compared with sterile ascitic fluid. 
Ascitic fluid should be cultured in blood culture bottles.  It is important to 
culture an adequate volume, 10-20ml/bottle.  It is also important to inoculate the 
bottles with ascitic fluid at the bedside.  A four-hour delay in inoculating the blood 
culture bottles results in a 25% reduction in detection of the cultures. 
BacT/Alert., is an automated calorimetric microbial detection system that 
provides an earlier microbiological diagnosis of bacteremia, than conventional bottles, 
without loss of sensitivity.  The time lapsed for ascitic fluid culture positivity was 13.3 
hours for BacT/Alert., and 43 hours for conventional blood culture bottles in patients 
with spontaneous bacterial peritonitis. 
 
  
MANAGEMENT      
    Empirical treatment of suspected spontaneous bacterial peritonitis must be 
started as soon as possible.   
1. Immediately after obtaining fluid for culture and analysis, when bacterial 
infections are clinically suspected based on signs and symptoms. 
2. When the neutrophil count of ascitic fluid is ≥ 250 cells/mm3. 
Before 1895, the combination of an aminoglycoside and a Beta lactam 
antibiotic was the most frequently used empiric antibiotic regimen in cirrhotic patients 
with spontaneous bacterial peritonitis.  Resolution of infection was achieved in less 
than 60% of patients and aminoglycoside nephrotoxicity developed in most cirrhotic 
patients even if aminoglycoside serum levels were below the toxic range. 
In 1985, Felisart et al., demonstrated in a randomised control trial that I.V. 
cefotaxime was more effective and less toxic than Ampicillin-Tobramycin 
combination in cirrhotics with severe infections.  The side effects were also negligible 
with cefotaxime and no one treated with cefotaxime developed drug induced ATN.41 
Similar studies worldwide showed similar experience, and aminoglycoside use was 
abandoned approximately 10 years ago.  The half-life of cefotaxime is prolonged in 
patients with cirrhosis when compared with the patients without liver disease.  
Therefore recent studies have focused in dose reductions in cirrhotic patients with 
spontaneous bacterial peritonitis. 42, 43  
  
Treatment given with 2.0 grams of cefotaxime given I.V. every 8 to 12 hours was as 
effective as a 6th hourly regimen in a randomised trial.43 The length of therapy has also 
been recently clarified, short course therapy (5days) has been shows to be as effective 
as long course therapy (10 days). 44 
Other 3rd generation cephalosporins such as ceftriaxone when given 2 grams 
per day cover most of the flora responsible for spontaneous bacterial peritonitis.  
Aztreonam and Amoxycillin plus clavulanic acid are some of the non-cephalosporin 
drugs that have been used in the treatment of spontaneous bacterial peritonitis.  
However the efficacy of Aztreonam when compared with amoxycillin plus clavulanic 
acid was less in the treatment of spontaneous bacterial peritonitis. 
Because of the relatively good conditions of most patients with spontaneous 
bacterial peritonitis during early phase of infection, treatment with oral antibiotics was 
suggested.  The oral Quinolones, which have good ascitic fluid penetration and a 
reasonably good spectrum of coverage, are also used. 
In patients with uncomplicated SBP (no gastrointestinal bleeding, hepatic 
encephalopathy, ileus, shock or renal failure), treatment with Ofloxacin or other oral 
quinolones for 8 days can be administered.45, 46, 47 
A good response to therapy can be evaluated by clinical criteria (disappearance 
of infection signs and symptoms), but the most important parameter remains the 
decrease to a half (from the pre-treatment value) of the PMN number in the ascitic 
fluid obtained by paracentesis after two days of treatment. 48 
  
Studies that require further confirmation propose the association of albumin 
infusion (1.5 g/kg body weight the first day, then 1 g/kg three more days) to the 
Cefotaxime treatment for patients with renal failure and SBP.  Albumin in these 
patients may improve the renal function by increasing the intravascular volume, 
because vasodilatation induced by cytokines released in excess reduces the effective 
arterial volume.46, 49 
Other adjuvant therapies in patients with SBP include prokinetics and 
probiotics. 
Prokinetics are used to shorten the intestinal transit time, reducing thus the 
intestinal bacterial overgrowth and the risk of bacterial translocation. 
Encouraging results have been obtained by using Cisapride and Propranolol, 
the latter’s β blocking effect antagonizes the increased adrenergic tone existent in 
patients with cirrhosis and responsible for the decreased intestinal motility. 
Probiotics are used for intestinal flora reequilibration, in favour to anaerobic 
protective bacteria.  Bacteriotherapy with Lactobacillus seems to correct intestinal 
bacterial overgrowth, to stabilize mucosal barrier function and to stimulate the local 
defence mechanisms.34, 50 
Oral treatment with conjugated bile acids (cholylglycine and cholylsarcosine) 
for preventing BT is under evalution.34    
 
  
FLOW CHART- II 
MANAGEMENT OF CIRRHOTIC PATIENTS WITH SBP 
High suspicion of Bacterial     Low suspicion of Bacterial 
Infections based on signs/     Infections based on signs/ 
Symptoms       symptoms 
  
 
 
Culture of AF, Blood,       Abdominal paracentesis: AF  
Urine, Sputum and AF /      Bacterial culture and PMN 
PMN count             count 
 
 
 
Ascitic fluid PMN count  
>250/mm3 
      (Within 24hours) 
 
 
Immediately start Empiric      Bacterial culture of Blood,    
      Antibiotic treatment     Urine and Sputum of blood 
(Cefotaxime 2gm/8-12hrs IV) 
 
 
 
 
  
TABLE - I 
RESULTS OF DIFFERENT ANTIBIOTIC TREATMENTS IN CIRRHOTIC 
PATIENTS WITH SBP 
 
AUTHOR 
(REFERENCE) 
ANTIBIOTIC DOSAGE 
NUMBER 
OF 
PATIENTS 
INFECTION 
RESOLUTION 
(%) 
SURVIVAL     
OF 
HOSPITALI 
SATION (%) 
Runyon44 Cefotaxime 2g/ 8 hrs 43 93 67.4 
Rimola43 
Cefotaxime 
Cefotaxime 
2g/6hrs.  
2g/12hrs 
66          
70 
77            
79 
69         
79 
Ariza51 Aztreonam 0.5 gm/8hrs. 16 56 63 
Gomez52 
Cefotaxime 
Cefonicid 
2g/24hrs 
2g/12hrs 
30          
30 
100           
94 
70           
63 
Grange53 Amp./Clauv. 1gm/6 hrs 27 85 60 
Navaeu54 
Oral oflox. 
Cefotaxime 
400mg/12hrs 
2gm/6hrs 
64          
59 
84.4          
84.7 
79.7        
80.9 
 
 
 
 
 
  
PROPHYLAXIS 
Prevention of bacterial infection should be considered in patients with liver 
disorders, who are at a high risk.  General measures that have been proposed to reduce 
the incidence of infections in cirrhotics include discontinuing alcohol intake, reducing 
the length of hospitalization, avoiding unnecessary instrumentation (especially bladder 
and IV catheters), improving the nutritional status and treating the complications of 
cirrhosis such as ascites formation and GI haemorrhage.  Because, enteric aerobic 
gram-negative bacteria are the most frequently isolated bacteria in spontaneous 
bacterial peritonitis, selective intestinal decontamination (SID) has been proposed as a 
method for the prevention.  SID consists of inhibition of the problematic gram-
negative flora of the gut with preservation of commensal bacteria.  Anaerobes 
comprise more than 99% of the gut flora and their presence is very important in 
preventing intestinal colonistation, overgrowth and subsequent extra–intestinal 
dissemination of pathogenic bacteria.  Randomised clinical trials have demonstrated 
efficacy of SID in preventing gram negative bacterial infection in neutropenic patients 
without overgrowth of resistant bacteria or significant side effect. 
There are three categories of cirrhotic patients which are more at risk of 
development SBP.  Patients with  
(1) GI hemorrhage 
(2) Ascitic fluid protein level < 1 g/dl 
(3) Previous history of SBP episode. 
  
For preventing SBP in patients with low ascitic fluid protein level, Norfloxacin 
is administrated during hospitalization.   
Patients with GI hemorrhage are more at a risk in developing SBP; it is 
considered that 20% of them have SBP at admission and 30-40% will develop an 
infection during hospitalization.  These patients will receive 800 mg/day Norfloxacin 
through the nasogastric tube for 7 days.47, 50 
In patients who survive an episode of SBP, a long-term prophylactic treatment 
(for preventing recurrence) with Norfloxacin 400 mg/day will be administered. 
When the oral administration or the administration by nasogastric tube 
Norfloxacin is not possible, Ciprofloxacin can be administered i.v.  In patients with 
intolerance to quinolones, the combination of trimethoprim / sulfamethoxazole for 5 
days / week can be used.   
Patients who receive primary or secondary prophylactic treatment with 
Norfloxacin can develop resistant gram-negative bacilli strains.  Fortunately, no 
crossed resistance between third generation cephalosporins and quinolones has been 
observed, thus infections caused by quinolone resistant germs can be treated with 
Cefotaxime or Ceftriaxone. 
Other prophylactic measures include: 
- Diuretics, which reduce the ascites volume and increase the ascitic fluid 
opsonic activity; 
- Local infections treatment and eradication, before their disseminations; 
  
- Porto-caval shunts and TIPS (transjugular intrahepatic portosystemic shunt) 
for GI hemorrhage or ascites risk reduction, reducing indirectly SBP risk;  
- Abstinence from alcohol in case of alcoholic cirrhosis.60         
 
CURRENT INDICATIONS FOR SID IN CIRRHOTIC PATIENTS 
TABLE – II 
GROUP DOSE OF NORFLOXACIN 
Cirrhotic patients with GI Haemorrhage 400 mg p.o.bd x7 days 
Cirrhotic patients with Ascitic fluid protein 
< 1gm/dl 
400 mg/day p.o. during the entire stay 
Cirrhotic patients who have survived an 
episode of SBP 
400 mg/day indefinitely or until liver 
transplantation 
 
 
Spontaneous bacterial peritonitis is a maker for advanced liver disease and poor 
survival.  Patients who survive an episode should be considered for liver 
transplantation.  Many patients who are awaiting liver transplantation in the west are 
receiving quinolone prophylaxis. 
    
 
  
MATERIALS AND METHODS 
This prospective study includes 75 patients with cirrhosis of liver with ascites 
diagnosed on the basis of clinical evaluation, biochemical investigations and 
ultrasonography admitted to the medical wards of the Thanjavur Medical College 
Hospital, Thanjavur during the period October 2005 to September 2007. 
The inclusion criteria were 
a) Patients with clinical features of cirrhosis with ascites. 
b) Ultrasonographic evidence of cirrhosis. 
c) Those who had not been started on antibiotics, before admission. 
The exclusion criteria were 
Patients with  
a) Non-cirrhotic portal fibrosis 
b) Cholelithiasis 
c) Hydatid cysts in the liver 
d) Secondaries in the liver 
e) Amoebic liver abscess 
f) Ascites due to renal, tubercular or malignant pathology. 
 
  
Liver cirrhosis was diagnosed on the basis of  
a) Biochemical abnormalities like serum Bilirubin, serum albumin, SGOT, 
SGPT. 
b) Ultrasonography showing shrunken or enlarged liver, nodular surface, 
increased echotexture, portal vein dilatation. 
c) Ascitic fluid study. 
There were 75 patients of whom 56 were males and 19 were females.  The age 
group was between 27 to 65years.  Mean age was 45.12 years.  The Proforma needed 
for the study took into account of the presenting clinical features of the patients on 
admission, the routine haemotological, bio-chemical investigations, ascitic fluid 
analysis and liver function tests. The ascitic fluid was analysed with utmost 
importance. 
ASCITIC FLUID ANALYSIS 
The samples were collected prior to the administration of antibiotics to the 
patients.  The skin was disinfected with povidone iodine solution.  The hands were 
scrubbed with soap and sterile disposable gloves were used to reduce the 
contamination of the skin.  As most patients had tense ascites, the technique of a ‘Z’ 
tract, which minimises leakage, was used.  About 10ml of the ascitic fluid was 
inoculated into the blood culture bottles at the bedside.  This methods was followed to 
get a higher yield as the delay in the inoculation reduced the detection of positive 
culture by 25%.51 The bottles were incubated for 72 hours and those of which showed 
  
growth were plated for identification.  Another 5ml was sent to the microbiological 
laboratory for culture by the conventional technique using agar plates as done 
routinely.  About 1ml of the fluid was sent for cell count and in all cases cell count 
was done as soon as possible.  The remainder of the fluid was sent for bio-chemical 
analysis.  The results were tabulated in the master chart to facilitate analysis. 
SBP was suspected clinically in patients presenting with fever, abdominal pain, 
tenderness and further confirmation was done by ascitic fluid cell count and culture. 
Statistical evaluation was performed and analysis done. 
 
                  
 
 
 
 
 
 
 
 
 
 
  
RESULTS 
 
In this study, out of 75 cirrhotic patients with ascites, the number of males 
were 56 (74.67%) while the number of females were 19 (25.33%).  The age groups 
ranged from 27 to 65 years.  The mean age was 45.12 years.  
TABLE III 
SEX 
NO. OF PATIENTS IN 
THE STUDY 
PERCENTAGE OF PATIENTS IN 
THE STUDY 
MALE 56 74.67% 
FEMALE 19 25.33% 
25.33%
74.67%
MALE
FEMALE
 
FIG.1 
 
 
  
PREVALENCE 
In this study, 19 out of  75 patients had spontaneous bacterial peritonitis, which 
means that 25.33% of cirrhotic patients with ascites had spontaneous bacterial 
peritonitis, on admission.  Hence the prevalence in this hospital was 25.33%. 
TABLE IV 
NO. OF PATIENTS IN 
THE STUDY 
NO. OF PATIENTS 
WITH SBP 
PREVALENCE 
75 19 25.33% 
 
74.67%
25.33%
SBP
NON-SBP
 
FIG. 2  
 
 
  
AGE WISE DISTRIBUTION OF SBP IN CIRRHOTIC PATIENTS 
In this study, 68.42% (13 out of 19) of patients with spontaneous bacterial 
peritonitis were in the age group of 41 to 50 years. 15.79 %( 3 out of 19) of patients 
with spontaneous bacterial peritonitis were in the age group of 51 to 60 years.  There 
were 2 patients in the age group of 31 to 40 years, constituting 10.53% and 1 patient 
in the age group of 61 to 70 years, constituting 5.26%. 
TABLE – V 
AGE IN YEARS 
(group) 
NO.OF 
PATIENTS 
WITH SBP 
PERCENTAGE 
0-10 - - 
11-20 - - 
21-30 - - 
31-40 2 10.53 
41-50 13 68.42 
51-60 3 15.79 
61-70 1 5.26 
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SEX DISTRIBUTION  
In this study, 25% (14 out of 56) of males and 26.32% (5 out of 19) of female 
patients had SBP. 
TABLE VI 
SEX 
NO. OF PATIENTS         
IN THE STUDY 
NO. OF 
PATIENTS 
WITH SBP 
PERCENTAGE 
MALE 56 14 25% 
FEMALE 19 5 26.32% 
42
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14
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CLINICAL FEATURES IN CIRRHOTIC PATIENTS WITH SBP 
TABLE – VII 
CLINICAL FEATURE NO. OF PATIENTS PERCENTAGE 
ABDOMINAL PAIN 16 84.21 
TENDERNESS 11 57.89 
FEVER 10 52.63 
GI BLEED 6 31.59 
HEPATIC 
ENCEPHALOPATHY 
2 10.53 
RENAL FAILURE 2 10.53 
31.59%
10.53%
57.89%
52.63%
84.21%
10.53%
Abdominal pain 
Tenderness
Fever
GI bleed
Hepatic
Encephalopathy
Renal failure
 
FIG. 5  
  
Abdominal pain constituted the major symptom in 84.21% of patients while 
abdominal tenderness was the next commonest feature occurring in 57.89% of cases.  
Fever occurred in 52.63% of cases.  GI bleed occured in 31.58% of cases, followed 
by hepatic encephalopathy and renal failure in 10.52% of cases each. 
CLINICAL FEATURES IN CIRRHOTIC PATIENTS WITHOUT SBP 
TABLE – VIII 
CLINICAL FEATURE NO. OF PATIENTS PERCENTAGE 
ABDOMINAL PAIN 19 33.93 
TENDERNESS 3 5.36 
FEVER 13 23.21 
GI BLEED 3 5.36 
HEPATIC ENCEPHALOPATHY 2 3.57 
RENAL FAILURE 2 3.57 
33.93%
5.36%
23.21%
5.36%
3.57% 3.57%
Abdominal pain 
Tenderness
Fever
GI bleed
Hepatic
encephalopathy
Renal failure
 
FIG. 6  
 
 
  
ASCITIC FLUID BIOCHEMISTRY  
 In this study, 16 out of 19 patients (84.21%) with spontaneous bacterial 
peritonitis had ascitic fluid protein level less than 1 gm/dl. The mean value of ascitic 
fluid protein in patients with spontaneous bacterial peritonitis was 0.88 gm/dl. The 
mean value of ascitic fluid protein in Non SBP patients was 1.1 gm/dL 
TABLE IX 
ASCITIC FLUID 
PARAMETER 
MEAN VALUE IN SBP 
PATIENTS 
MEAN VALUE IN NON 
SBP PATIENTS 
PROTEIN 0.88 gm/dl 1.1 gm/dl 
 
SEVERITY OF LIVER DISEASE 
The serum bilirubin was elevated in all patients with spontaneous bacterial 
peritonitis, with a mean value of 2.66% mg/dl.  The PT was prolonged by at least 2 
times than that of control, in 14 out of 19 patients, that is 73.68% of patients with 
spontaneous bacterial peritonitis.  The serum albumin was reduced in all SBP patients 
with a mean value of 3.03 gm/dl.                                                                                                          
TABLE X 
LIVER PARAMETER MEAN VALUE IN SBP PATIENTS 
SERUM BILIRUBIN 2.66mg/dl 
SERUM ALBUMIN 3.03gm/dl 
PROTHROMBIN TIME 2 X CONTROL 
 
  
CHILD’S CRITERIA FOR GRADING THE SEVERITY OF LIVER DISEASE 
In this study, out of 19 patients with SBP, 14 patients (73.68%) were in child’s 
class C, 4 patients (21.05%) were in child’s class B and 1 patient (5.26%) was in 
child’s class A. 
TABLE XI 
CHILD’S CLASS 
NO. OF PATIENTS 
WITH SBP 
PERCENTAGE 
A 1 5.26% 
B 4 21.05% 
C 14 73.68% 
 
5.26%
21.05%
73.68%
A
B
C
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ASCITIC FLUID CULTURE 
Ascitic fluid cultures using blood culture bottles detected growth in all cases of 
spontaneous bacterial peritonitis where as conventional methods could do so only in 
47.37% of cases 
 
TABLE XII 
METHOD 
NO. OF PATIENTS 
WITH SBP YIELDED 
GROWTH 
PERCENTAGE OF 
DETECTION 
BLOOD CULTURE 
BOTTLE 
19 100% 
CONVENTIONAL 9 47.37% 
 
 
FIG 8 
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VARIANTS OF ASCITIC FLUID INFECTIONS 
 More over in this study, out of the 75 cirrhotic patients with ascites 10 
(10.33%) patients had positive culture for one organism, but the neutrophil cell count 
was less than 250 cells/mm3.  This group of patients had mono-microbial 
nonneutrocytic ascites. 
TABLE XIII 
Sl.No VARIANTS OF A.F.I 
NO. OF 
PATIENTS 
PERCENTAGE
1 Spontaneous Bacterial Peritonitis 19 25.33% 
2 Mono-microbial non neutrocytic ascites 10 10.33% 
3 Culture negative neutrocytic ascites 0 0 
4 Secondary bacterial peritonitis 0 0 
5 Poly-microbial bacterascites. 0 0 
0% 0%
25.33%
10.33%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
SBP MNA CNNA PMB
SBP
MNA
CNNA
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MICROBIOLOGICAL PROFILE 
TABLE XIV 
ORGANISM NO. OF PATIENTS PERCENTAGE 
E.COLI 8 42.11% 
KLEBSIELLA PNEUMONIAE 7 36.84% 
PROTEUS 2 10.53% 
PSEUDOMONAS 1 5.27% 
STAPHYLOCOCCUS AUREUS 1 5.27% 
 
FIG 10 
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E.coli was the most common pathogen isolated in 42.11% (8 out of 19) of the 
patients with spontaneous bacterial peritonitis, while Klebsiella pneumoniae was 
isolated in 36.84% (7 out of 19) of the patients followed by Proteus in two patients, 
that is 10.53%, Pseudomonas in one patient, that is 5.27% and Staphylococcus 
aureus in one patient, that is 5.27%.   
          
 
 
 
      
 
 
 
 
 
 
 
 
 
  
DISCUSSION 
PREVALENCE 
In this study, the prevalence of spontaneous bacterial peritonitis in cirrhotics 
with ascites was 25.33% (19 out of 75 patients).  TABLE IV 
In various studies world wide, the cumulative probability of spontaneous 
bacterial peritonitis occuring during hospitalization in a patient with cirrhosis has been 
reported to vary from 8 % to 27 % 3, 4.  
.    In the present study it was seen in 25.33 % of the patients.  Bacterial 
colonisation of ascitic fluid is related to its markedly deficient bacterial and opsonic 
activity in cirrhosis.  In this context, alcoholic and non-alcoholic cirrhosis behaves in a 
similar fashion. 
AGE AND SEX DISTRIBUTION 
Among 75 patients with cirrhosis and ascites admitted to this hospital 74.67 % 
were males where as females constituted only 25.33 %.  This could be explained by 
the fact that, a large group of cirrhotic patients in our part is due to alcoholism and 
female alcoholics are fewer in numbers. 
The prevalence of spontaneous bacterial peritonitis was maximum in the age 
group of 41 to 50 years, which is 73.69%. Out of which, 84.62% (11out of 13 
patients) were males and 15.38% (2 out of 13 patients) were females. TABLE V 
  
Studies have shown that incidence of spontaneous bacterial peritonitis is equal 
in all age groups. However, in this study prevalence was maximum in the age group of 
41 to 50 years. This could be explained by the fact that mean age in this study was 
45.12 years.  
In this study, 25% (14 out of 56) of males and 26.32% (5 out of 19) of female 
patients had SBP. TABLE VI 
Studies have shown that both sexes are affected equally with spontaneous 
bacterial peritonitis in patients with ascites.  
CLINICAL FEATURES 
The main presenting feature was abdominal pain seen in 84.21%     (16 out of 
19 patients) of patients with spontaneous bacterial peritonitis, while abdominal 
tenderness was present in 57.89% (11out of 19 patients) of patients.  Fever was a 
presenting feature in 52.63% (10 out of 19 patients) of patients with spontaneous 
bacterial peritonitis, while only 23.21% (13 out of 56 patients) of patients without 
spontaneous bacterial peritonitis had fever.  TABLE VII 
               In the study by N.Venkataraman, N.Kasirajan et al., vague abdominal 
pain was the only symptom present in the patients with spontaneous bacterial 
peritonitis.        
. 
Upper GI bleed was present in 31.58% (6 out of 19 patients) of patients who 
were diagnosed as spontaneous bacterial peritonitis.  Bleichner G et al., showed that 
  
more than 20 % of cirrhotics with GI bleed are infected at the time of admission.     
Rimola et al., and Soriano et al., also showed that the bacterial infection develops in 
an additional 30% of those with upper GI bleed during hospitalisation usually during 
the first 3 to 4 days. 31, 43    
Hepatic encephalopathy and renal failure was seen in 10.53% (2 out of 19 
patients) of patients with spontaneous bacterial peritonitis at presentation. 
SEVERITY OF LIVER DISEASE 
The severity of liver disease is a major risk factor for the development of 
spontaneous bacterial peritonitis.3, 39, 55 Severity is assessed by increased prothrombin 
time and increased serum bilirubin levels.  
In this study, serum bilirubin was elevated in all patients with spontaneous 
bacterial peritonitis, with a mean level of 2.66% mg/dl. 
In the study by Cirera I ,Bauer TM ,Navasa M et al, 19 serum bilirubin level 
>2.5 mg/dl is an independent predictive factor of SBP.  In this study mean level of 
serum bilirubin in SBP patients was 2.66 mg/dl. 
The PT was prolonged by at least 2 times than that of control, in 73.68% (14 
out of 19) of patients with spontaneous bacterial peritonitis.      
In the Study by Guarner, C., Runyon BA, 56 95% of patients with 
spontaneous bacterial peritonitis can have increased serum bilirubin levels and 98% 
  
of patients can have abnormal PT. In this study, serum bilirubin was elevated in all 
patients and PT was abnormal in 73.68% of patients 
In this study, out of 19 patients with SBP, 14 patients (73.68%) were in child’s 
class C, 4 patients (21.05%) were in child’s class B and 1 patient (5.26%) was in 
child’s class A.               
Studies have shown that 70% of patients who develop SBP were in child C 
class. In this study 73.68% of patients were in child C class. 
ASCITIC FLUID ANALYSIS 
In this study, 16 out of 19 patients (84.21%) with spontaneous bacterial 
peritonitis had ascitic fluid protein level less than 1 gm/dl. The mean value of ascitic 
fluid protein in patients with spontaneous bacterial peritonitis was 0.88 gm/dl. The 
mean value of ascitic fluid protein in Non SBP patients was 1.1 gm/dL 
           Runyon and associates have shown that cirrhotic patients with ascitic fluid 
protein levels of 1 gm/dl or less had ten fold increased risk for the development of 
spontaneous bacterial peritonitis, when compared to cirrhotic patients with ascitic 
fluid levels greater than 1 gm/dl.51 This clearly shows that a low ascitic fluid proteins 
level is a predisposing factor for spontaneous bacterial peritonitis.  
 
 
 
 
  
ASCITIC FLUID CULTURE 
The blood culture bottles detected growth in all cases of spontaneous bacterial 
peritonitis, while the conventional methods could do so only in 47.37% of cases [9 
out of 19], implying the superiority of the inoculation method, TABLE XII .Similar 
experience has been of Pawar et al., too.58 
A study by Runyon BA, HOEFS JC, 6 has shown that 35% to 58% of 
patients with spontaneous bacterial peritonitis are culture negative by conventional 
methods. In this study 47.37% of patients with spontaneous bacterial peritonitis are 
culture negative by conventional method.  
Multiple studies have demonstrated superior sensitivity in using blood culture 
bottles for culture of ascitic fluid compared with the conventional techniques.59,60,61  
Further Runyon BA, Antillon MR and other 62 have shown that bedside inoculation 
of ascitic fluid is superior to the delayed laboratory inoculation of blood culture 
bottles with ascitic fluid. 
MICROBIOLOGICAL PROFILE  
E.coli was the most common pathogen isolated in 42.11% (8 out of 19) of the 
patients with spontaneous bacterial peritonitis, while Klebsiella pneumoniae was 
isolated in 36.84% (7 out of 19) of the patients followed by Proteus in two patients, 
that is 10.53%, Pseudomonas in one patients, that is 5.27% and Staphylococcus 
aureus in one patient, that is 5.27%.TABLE IV 
Studies by Runyon BA and Wiest R Garcia-TsaoG 33,34 have shown more 
than 60% of SBP episodes are produced by Gram-negative enteric bacilli – E.coli and 
  
Klebsiella pneumonia being the most frequently isolated organisms.  In this study 
E.coli and Klebsiella pneumonia were isolated in 78.95% of SBP patients. 
           The commonest organism was E.coli followed by Klebsiella pneumoniae, like 
Monserrat et al., 63 who also isolated enteric organisms, in his study. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CONCLUSION 
1. Prevalence of Spontaneous Bacterial Peritonitis in this study was 25.33%. 
2. The most common presenting feature of SBP was abdominal pain followed by 
abdominal tenderness and fever. Since a large percentage of patients had 
abdominal pain, one must have high index of suspicion of SBP and should do 
cytology and culture of the ascitic fluid, more so, when the patient is febrile 
and abdominal tenderness is present. 
3. Low ascitic fluid protein is a predisposing factor for Spontaneous Bacterial 
Peritonitis.   
4. Severe Liver cell dysfunction as evidenced by the increased serum bilirubin 
and prolonged prothrombin time has been associated with the increased 
incidence of Spontaneous Bacterial Peritonitis.  
5. Spontaneous Bacterial Peritonitis is a common complication in Child’s class 
B and C cirrhotic patients. 
6. Ascitic fluid culture using the blood culture bottles with bedside inoculation 
is superior to the conventional routine culture methods and it should be 
done in all suspected cases of Spontaneous Bacterial Peritonitis. 
 
 
 
  
7. The commonest organism isolated was E.coli followed by K.pneumoniae. 
8. Early recognition and treatment of SBP could reduce the morbidity and 
mortality of patients with cirrhosis liver and ascites and improve their quality 
of life. 
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PROFORMA 
SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS LIVER   
WITH ASCITES 
NAME              AGE   SEX: M / F.   IP NO: WARD 
COMPLAINTS     DURATION 
Fever 
Pain Abdomen 
Jaundice 
UGI bleed 
Oliguria 
Altered Sensorium 
 
PERSONAL HISTROY 
Alcoholism : Y / N   
 
PHYSICAL FINDINGS 
Nutrition     Pulse: 
Icterus     BP: 
Flapping Tremor    Temp: 
 EXAMINATION OF ABDOMEN 
  
TENDERNESS  
FREE FLUID  
ORGANOMEGALY 
 
INVESTIGATIONS 
BLOOD 
SUGAR UREA CREAT. ELECT. Na K Hco3 
PROTHROMBIN TIME  
URINE 
ALB  SUGAR DEPOSITS  C & S 
USG ABDOMEN   PORTAL VEIN    ASCITES 
ASCITIC FLUID ANALYSIS      PH. PROTEIN  CELL COUNT 
ASCITIC FLUID CULTURE  
     BLOOD CULTURE 
     CONVENTIONAL 
LIVER FUNCTION TEST 
SGOT SGPT BILIRUBIN DIRECT INDIRECT TOTAL 
PROTEIN 
ALBUMIN GLOBUMIN RATIO 
 
 
 
  
CHILD’S CRITERIA FOR GRADING THE SEVERITY OF LIVER  
DISEASE 
 
CRITERIA A (minimal) B (moderate) C (advanced) 
S.bil.(mg/dl) < 2 2-3 >3 
S.alb. (g/dl) >3.5 3.0-3.5 < 3.0 
Ascites None Easily controlled Poorly controlled 
Neurologic disorder None minimal Advanced 
Nutrition Excellent good Poor 
 
 
 
 
 
 
 
 
 
 
  
ABBREVIATIONS 
SBP  -  Spontaneous Bacterial Peritonitis 
PMN - Polymorphonuclear 
AF -  Ascitic Fluid 
AFI -  Ascitic Fluid Infection 
CNNA-  Culture Negative Neutrocytic Ascites 
BT -  Bacterial Translocation 
NO  -  Nitric Oxide 
GI  -  Gastro Intestine 
SID  -  Selective Intestinal Decontamination 
MNB - Mono Microbial Non-Neutrocytic Ascites 
 
    
S. No Name A/S IP.NO Fever Pain Ab. Tend UGI BI. Jaundice Ascites Oliguria Altered sensorium Asterexis Nutrition 
S.Alb. 
G/dl 
S.Bil. 
mg/dl BI. Urea S. Cr. PT Child’s class 
ASCITIC FLUID CULTURE 
Protein 
mg/Dl 
PMN Cell 
count 
/mm3 
Convent 
ional Bed side Organism 
1 Lakhsmanan 60/M 855024 + + - + + + + + + Poor 28 5 54 2.8 + C 0.9 320 - + E coli 
2 Samiammal 42/F 889086 - - - - - + - - - Excel 3.1 1 36 0.8 - A 1.2 100 - - - 
3 Kaveri 45/F 873185 + - - - - + - - - Excel 3 0.8 37 0.8 - A 1.4 80 - - - 
4 Elangovan 45/M 886274 + + - - - + - - - Poor 3.2 2.1 40 0.9 - C 0.8 340 + + 
Klebsiella  
pneumoniae 
5 Kumaraguru 32/M 908529 - - - - - + - - - Excel 3.1 1 35 0.8 - A 1.3 110 -  - 
6 Parthasarathy 65/M 867800 + - - - - + - - - Poor 3.3 2 38 0.8 - C 0.9 270 + + 
Klebsiella  
pneumoniae 
7 Ramachandran 42/M 922849 - - - - - + - - - Excel 3.2 1.1 36 0.9 - A 1.1 140 - - - 
8 Selvam 45/M 838399 + + - - - + - - -- Excel 3.1 1 38 0.9 - A 1.5 140 - - Proteus 
9 Vembu 40/M 876558 - - - - - + - - - Excel 3.2 2 32 0.8 - A 1.2 110 - - - 
10 Chellakkannan 55/M 827472 - + - - - + - - - Poor 3 2.2 39 0.9 + C 0.9 280 + + Pseudomonas 
11 Ulaganathan 45/M 839898 + + - + + + - - - Poor 3 2 45 1.6 + C 1.2 300 + + Proteus 
12 Chinnaponnu 40/F 828574 - - - - - + - - - Poor 3.1 2.1 35 0.8 - C 1.4 260 + + 
Klebsiella  
pneumoniae 
13 Ayyakkannu 48/M 836108 - + - - - + + - - Good 3.2 2.5 52 2.2 + B 1.3 270 + + 
Klebsiella  
pneumoniae 
14 Kulanthai Therass 41/F 877726 + + - -- - + - - - Excel 3.2 1 35 0.8 - A 1.1 90 - - - 
15 Murugnandam 43/M 875559 - + - - - + - - - Excel 2.9 1.1 37 0.9 - A 1 80 - - - 
16 Balumani 43/M 889159 + + - - + + - - - Poor 3.2 2.5 41 1.1 + C 0.8 300 - + E coli 
17 Selvam 42/M 828605 + + - - - + - - - Excel 3.3 2.8 39 0.8 - A 0.9 110 - - 
Klebsiella  
pneumoniae 
18 Subramani 47/M 900584 + + - - - + - - - Poor 3.1 3 40 0.9 + C 0.95 340 - + E coli 
19 Dhanalakshmi 45/F 843359 + + - + + + + + + Poor 2.2 6.5 65 3.2 + C 0.7 460 + + 
Klebsiella  
pneumoniae 
20 Noorjahan 42/F 840354 + + - - - + - - - Poor 3.2 2 36 0.8 - C 0.9 300 + + Proteus 
21 Murugaiyan 40/m 838446 - - - - - + - - - Poor 3.2 2.8 35 0.8 - C 0.9 80 + + 
Klebsiella  
pneumoniae 
22 Ganapathy 65/M 955289 - - - - - + - - - Excel 3.1 0.6 38 0.9 - A 0.95 70 - - - 
23 Mohanraj 30/M 869355 - - - + + + - - - Good 3 2 38 0.8 - B 0.8 310 - + E coli 
24 Parimala 40/F 845381 + - - - - + - - - Excel 3 0.7 36 0.9 - A 0.9 160 - - Klebsiella  
pneumoniae 
25 Rajendran 35/M 909517 + + - - - + - - - Excel 2.9 0.6 35 0.8 - A 0.8 50 - - - 
26 George 41/M 867500 - + - - - + - - - Good 3.1 2.1 35 0.8 - B 0.85 70 - + Staphylococcus 
aureus 
27 Selvaraj 43/M 846980 - - - - - + -- - - Excel 3.1 0.5 36 0.7 - A 0.9 90 - - - 
28 Raju 42/M 825864 - + - - - + - - - Good 3.2 1 38 0.9 - B 0.5 80 - - - 
29 Rengaraj 45/M 825551 + + - + + + - - - Poor 3 2.5 46 1.2 + C 0.4 310 - + E coli 
30 Lakhsmanan 41/M 844278 - + - - + + - - - Good 3.2 2.1 35 0.9 - B 0.95 260 - + E coli 
31 Marimuthu 46/M 827832 + + - + - + + + + Poor 2.5 4.9 58 2.9 + C 0.7 110 - - E.coli 
32 Chellappan 43/F 869589 - - - - + + - - - Excel 2.8 0.8 31 0.8 - A 1.1 110 - - - 
33 Karuppusamy 45/M 828725 - - - - - + - - - Excel 2.7 0.9 35 0.8 - A 0.8 130 - - - 
34 Natarajan 35/M 908749 - + - - - + - - - Excel 3 0.7 36 0.6 - A 0.9 100 - - - 
35 Kali 36/M 922180 - - - - - + - + - Excel 3.1 1 38 0.7 - A 1.1 110 - - - 
36 Pondy 42/M 867582 - - - - -- + - - - Excel 3 1 32 0.9 - A 1 90 - - - 
37 Muthusamy 49/M 879593 + + - + + + + - + Poor 2.4 5.2 68 3.2 + C 0.6 140 - - E.coli 
38 Veeran 50/M 872527 - - - -- - + - - - Excel 3.1 0.8 32 0.6 - A 0.9 110 - - - 
39 Kaliaperumal 52/M 900835 - - - - - + - - - Excel 3 0.7 35 0.8 - A 0.8 100 - - - 
40 Tamilselvi 47/F 865359 - + - - - + - - - Excel 3.1 0.7 38 0.9 - A 0.7 80 - - - 
41 Kuppusamy 48/M 958438 - - - - - + - - - Excel 2.8 0.6 39 0.7 - A 0.9 20 - - - 
42 Samaiyan 55/M 859037 - - - - - + - - - Excel 2.6 0.8 36 0.6 - A 0.8 200 - - E.coli 
43 Sudhaker 50/M 891737 + + - + + + - - - Good 3.5 2.7 55 1.9 + B 0.7 100 - - - 
44 Ramya 48/M 920547 - - - - - + - - - Excel 2.7 0.8 37 0.8 - A 0.9 150 - - - 
45 Thavamani 55/F 957324 - - - - - + - - - Excel 2.6 0.4 38 0.9 - A 0.9 90 - - - 
46 Rajamanickam 41/M 870499 + + - - - + - - - Excel 3 2.4 36 0.8 + A 0.5 290 - + E coli 
47 Sivakumar 43/M 930377 + + - - - + -- - - Excel 3.1 1.1 35 1.1 - A 0.8 130 - - Klebsiella  
pneumoniae  
48 Radhika 40/F 878335 + + - - - + - - - Excel 3.1 1 37 0.8 - A 0.9 100 - - - 
49 Anbu 48/M 846983 - - - - - + - - - Excel 3.2 0.8 31 0.6 - A 0.7 130 - - - 
50 Raju 49/M 865881 - - - - - + - - - Excel 3.3 0.7 30 0.9 - A 0.9 80 - - - 
51 Subramanian 42/M 866192 - - - - - + - - - Excel 3.2 0.5 35 0.7 - A 0.6 50 - - - 
52 Saminathan 53/M 879311 + + - - - + - - - Excel 3.0 0.9 33 0.8 - A 0.8 100 - - E.coli 
53 Senbagam 58/F 873241 + + - - - + - - - Poor 3.2 2.1 37 0.9 - C 0.8 280 + + E coli 
54 Andiappan 52/M 869984 + - - - - + - - - Excel 3.1 0.7 30 0.8 - A 0.7 70 - - - 
55 Maheswaran 46/M 840238 + + - + + + + - - Poor 3.5 2.2 52 2.2 + C 0.8 410 - + Klebsiella  
pneumoniae 
56 Samiappan 50/M 870148 - - - - - + - - - Excel 3.2 0.5 28 0.8 - A 0.6 90 - - - 
57 Anusuya 60/F 958175 - - - - - + - - - Excel 3.3 0.8 29 0.8 - A 0.9 100 - - - 
58 Indira 35/F 917028 - + - - - + - - - Good 3.1 0.6 31 0.7 - B 0.8 70 - - - 
59 Manavalan 46/F 868179 - - - - - + - - - Excel 3.3 0.9 35 0.8 - A 0.6 180 - - E.coli 
60 Tholappan 49/M 907835 - - - - - + - - - Excel 3.2 1 30 0.9 - A 0.8 80 - - - 
61 Sethuraman 60/M 842433 + + - - - + - - - Excel 3 1.1 26 1 - A 0.9 60 - - - 
62 Ilavarasan 42/M 867415 + + - - - + - - - Good 2 0.8 28 0.4 - B 0.7 90 - - - 
63 Xavier 46/M 882344 - - - - - + - - - Excel 2.6 0.5 30 0.7 - A 0.6 110 - - - 
64 Rajendran 27/M 826773 - - - - - + - - - Excel 3.2 0.8 31 0.6 - A 0.8 90 - - - 
65 Seetharaman 36/M 827793 - + - - - + - - - Excel 3.1 0.8 29 0.8 - A 0.9 100 - - - 
66 Mohanraj 42/M 912191 - - - - - + - - - Excel 2.9 0.7 30 0.6 - A 0.8 90 - - - 
67 Parimala 45/F 953949 - - - -- - + - - - Excel 3 0.9 35 0.8 - A 1.1 70 - - - 
 68 Selvakumar 41/M 841109 - - - - - + - - - Excel 2.8 0.6 31 0.9 - A 0.8 100 - - - 
69 Kamala 53/F 840050 - - - - - + - - - Good 3.1 0.9 33 1.1 - B 1 130 - - E.coli  
70 Suriyagandhi 35/F 830909 - - - - - + - - - Excel 2.9 0.8 39 0.9 - A 0.8 110 - - - 
71 Seethalakshmi 40/F 867733 - + - - - + - - - Excel 2.8 0.7 35 0.7 - A 1 100 - - - 
72 Arumugam 48/M 840890 - - - - - + - - - Excel 3.2 0.9 40 0.8 - A 0.8 90 - - - 
73 Ponnuram 42/M 830574 - - - - - + - - - Good 3.1 0.6 35 0.6 - B 0.9 70 - - - 
74 Chandrasekar 39/M 882491 - - - - - + - - - Excel 3 0.7 33 0.8 - A 1.1 80 - - - 
75 Kamalakannan 46/M 827469 - - - - - + - - - Excel 2.9 0.6 30 0.6 - A 1 100 - - - 
